37
Participants
Start Date
April 1, 2019
Primary Completion Date
May 30, 2023
Study Completion Date
November 30, 2023
Rituximab
Patients will receive two doses of rituximab 1 g at two-week interval and one dose of rituximab 1 g at month 6
Placebo
Patients will receive two doses of placebo at two-week interval and one dose of placebo at month 6
IRCCS Istituto Clinico Humanitas, Rozzano
Ospedale Mondino di Pavia
UNKNOWN
University of Turin, Italy
OTHER
Istituto Neurologico Carlo Besta di Milano
UNKNOWN
San Raffaele University Hospital, Italy
OTHER
Università di Messina
UNKNOWN
Universita degli Studi di Genova
OTHER
Istituto Di Ricerche Farmacologiche Mario Negri
OTHER
Università di Napoli Federico II
UNKNOWN
Istituto Clinico Humanitas
OTHER